Wedelolactone

Wedelolactone is a lipid of Polyketides (PK) class. Wedelolactone is associated with abnormalities such as CLEFT LIP, CONGENITAL HEALED and Hepatitis. The involved functions are known as Signal Transduction, Cell Cycle Arrest, Apoptosis, luciferase activity and Metabolic Inhibition. Wedelolactone often locates in Protoplasm and Smooth muscle (tissue). The associated genes with Wedelolactone are CFB gene, Candidate Disease Gene, JAK2 gene, STAT2 gene and STAT3 gene.

Cross Reference

Introduction

To understand associated biological information of Wedelolactone, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Wedelolactone?

Wedelolactone is suspected in CLEFT LIP, CONGENITAL HEALED, Hepatitis and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Wedelolactone

PubChem Associated disorders and diseases

What pathways are associated with Wedelolactone

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Wedelolactone?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Wedelolactone?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Wedelolactone?

There are no associated biomedical information in the current reference collection.

What genes are associated with Wedelolactone?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Wedelolactone?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with Wedelolactone

Download all related citations
Per page 10 20 50 100 | Total 111
Authors Title Published Journal PubMed Link
Gao W et al. Distinct regulation of host responses by ERK and JNK MAP kinases in swine macrophages infected with pandemic (H1N1) 2009 influenza virus. 2012 PLoS ONE pmid:22279582
Rance E et al. Inhibition of IκB kinase by thalidomide increases hepatitis C virus RNA replication. 2012 J. Viral Hepat. pmid:22239529
Zhang W et al. Activation of nuclear factor-κB pathway is responsible for tumor necrosis factor-α-induced up-regulation of endothelin B2 receptor expression in vascular smooth muscle cells in vitro. 2012 Toxicol. Lett. pmid:22207076
Dos Santos JI et al. Structural and functional studies of a bothropic myotoxin complexed to rosmarinic acid: new insights into Lys49-PLAâ‚‚ inhibition. 2011 PLoS ONE pmid:22205953
Upadhyay K et al. Development and characterization of phyto-vesicles of wedelolactone for hepatoprotective activity. 2012 Drug Dev Ind Pharm pmid:22204306
Jie L et al. Minimally modified LDL upregulates endothelin type B receptors in rat coronary artery via ERK1/2 MAPK and NF-κB pathways. 2012 Biochim. Biophys. Acta pmid:22198514
Li J et al. Minimally modified LDL upregulates endothelin type B receptors in rat basilar artery. 2012 Microvasc. Res. pmid:22198335
Prakash T et al. Neuroprotective activity of Wedelia calendulacea on cerebral ischemia/reperfusion induced oxidative stress in rats. 2011 Indian J Pharmacol pmid:22144773
Zerbini LF et al. Combinatorial effect of non-steroidal anti-inflammatory drugs and NF-κB inhibitors in ovarian cancer therapy. 2011 PLoS ONE pmid:21931671
Bharadwaj U et al. Mesothelin confers pancreatic cancer cell resistance to TNF-α-induced apoptosis through Akt/PI3K/NF-κB activation and IL-6/Mcl-1 overexpression. 2011 Mol. Cancer pmid:21880146